93例70岁以上多发性骨髓瘤患者的临床特点及转归

目的探索老年多发性骨髓瘤(MM)患者的临床特征以及转归。方法回顾性分析2011年8月至2016年8月第二军医大学长征医院收治的93例70岁以上的初发MM患者的临床特征,根据患者初发时的年龄、日常生活能力评分、日常生活能力量表、Charlson合并症指数,按照Palumbo等提出的健康评估系统,将评分为0分的归为健康,评分为1分的归为中等健康,评分i〉2分的归为健康状况差。分析三组患者的治疗反应率、疾病无进展生存(PFS)时间以及总生存(Os)时间。结果93例患者中,健康、中等健康、健康状况差组分别为15例、31例和47例,三组完全缓解(CR)率分别为60.0%、22.6%、12.8%(Fish...

Full description

Saved in:
Bibliographic Details
Published in中华血液学杂志 Vol. 38; no. 9; pp. 744 - 748
Main Author 陈海敏 周帆 韦苇 彭嵘 石昊天 侯健
Format Journal Article
LanguageChinese
Published 第二军医大学长征医院闸北分院血液科, 上海,200070%第二军医大学长征医院血液科 2017
Subjects
Online AccessGet full text
ISSN0253-2727
DOI10.3760/cma.j.issn.0253-2727.2017.09.003

Cover

Abstract 目的探索老年多发性骨髓瘤(MM)患者的临床特征以及转归。方法回顾性分析2011年8月至2016年8月第二军医大学长征医院收治的93例70岁以上的初发MM患者的临床特征,根据患者初发时的年龄、日常生活能力评分、日常生活能力量表、Charlson合并症指数,按照Palumbo等提出的健康评估系统,将评分为0分的归为健康,评分为1分的归为中等健康,评分i〉2分的归为健康状况差。分析三组患者的治疗反应率、疾病无进展生存(PFS)时间以及总生存(Os)时间。结果93例患者中,健康、中等健康、健康状况差组分别为15例、31例和47例,三组完全缓解(CR)率分别为60.0%、22.6%、12.8%(Fisher χ2=12.398,P=0.002)。三组的中位PFS时间分别为31、24和13个月(χ2=17.832,P〈0.001),中位OS时间分别为未达到、58个月和25个月(χ2=40.678,P〈0.001)。在47例健康状况差的患者中,应用含有新药(蛋白酶体抑制剂或免疫调节剂)化疗方案的较未应用新药的患者可获得更长PFS时间(17个月对9个月,χ2=6.454,P=0.011);CR患者PFS和OS时间均明显长于未达CR的患者(PFS:24个月对12个月,χ2=4.117,P=0.042;OS:37个月对25个月,χ2=6.507,P=0.011)。结论健康状况影响老年MM患者的治疗反应率、PFS及OS。对健康状况差的老年MM患者,使用含有新药的化疗方案可延长PFS时间,且获得CR的患者PFS及OS时间更长。
AbstractList 目的探索老年多发性骨髓瘤(MM)患者的临床特征以及转归。方法回顾性分析2011年8月至2016年8月第二军医大学长征医院收治的93例70岁以上的初发MM患者的临床特征,根据患者初发时的年龄、日常生活能力评分、日常生活能力量表、Charlson合并症指数,按照Palumbo等提出的健康评估系统,将评分为0分的归为健康,评分为1分的归为中等健康,评分i〉2分的归为健康状况差。分析三组患者的治疗反应率、疾病无进展生存(PFS)时间以及总生存(Os)时间。结果93例患者中,健康、中等健康、健康状况差组分别为15例、31例和47例,三组完全缓解(CR)率分别为60.0%、22.6%、12.8%(Fisher χ2=12.398,P=0.002)。三组的中位PFS时间分别为31、24和13个月(χ2=17.832,P〈0.001),中位OS时间分别为未达到、58个月和25个月(χ2=40.678,P〈0.001)。在47例健康状况差的患者中,应用含有新药(蛋白酶体抑制剂或免疫调节剂)化疗方案的较未应用新药的患者可获得更长PFS时间(17个月对9个月,χ2=6.454,P=0.011);CR患者PFS和OS时间均明显长于未达CR的患者(PFS:24个月对12个月,χ2=4.117,P=0.042;OS:37个月对25个月,χ2=6.507,P=0.011)。结论健康状况影响老年MM患者的治疗反应率、PFS及OS。对健康状况差的老年MM患者,使用含有新药的化疗方案可延长PFS时间,且获得CR的患者PFS及OS时间更长。
目的 探索老年多发性骨髓瘤(MM)患者的临床特征以及转归.方法 回顾性分析2011年8月至2016年8月第二军医大学长征医院收治的93例70岁以上的初发MM患者的临床特征,根据患者初发时的年龄、日常生活能力评分、日常生活能力量表、Charlson合并症指数,按照Palumbo等提出的健康评估系统,将评分为0分的归为健康,评分为1分的归为中等健康,评分≥2分的归为健康状况差.分析三组患者的治疗反应率、疾病无进展生存(PFS)时间以及总生存(OS)时间.结果 93例患者中,健康、中等健康、健康状况差组分别为15例、31例和47例,三组完全缓解(CR)率分别为60.0%、22.6%、12.8% (Fisher x2=12.398,P=0.002).三组的中位PFS时间分别为31、24和13个月(x2=17.832,P< 0.001),中位OS时间分别为未达到、58个月和25个月(x2=40.678,P< 0.001).在47例健康状况差的患者中,应用含有新药(蛋白酶体抑制剂或免疫调节剂)化疗方案的较未应用新药的患者可获得更长PFS时间(17个月对9个月,x2=6.454,P=0.011);CR患者PFS和OS时间均明显长于未达CR的患者(PFS:24个月对12个月,x2=4.117,P=0.042;OS:37个月对25个月,x2=6.507,P=0.011).结论 健康状况影响老年MM患者的治疗反应率、PFS及OS.对健康状况差的老年MM患者,使用含有新药的化疗方案可延长PFS时间,且获得CR的患者PFS及OS时间更长.
Abstract_FL Objective To explore the clinical features and prognostic factors of elderly MM patients.Methods A retrospectively analysis of clinical characteristics in 93 newly diagnosed MM patients with more than 70 years of old between August 2011 and August 2016.Based on age,basic activities of daily living scale,instrumental activities of daily living scale,Charlson comorbidity index at diagnosis,patients were divided into three groups:Fit (score =0,n =15),Intermediate fitness (score =1,n =31),Frail (score≥2,n =47) according to a geriatric assessment system proposed by Antonio Palumbo et al.The treatment response rate,progression free survival time (PFS) and overall survival (OS) of the three groups were analyzed.Results Complete remission was 60.0% in Fit,22.6% in Intermediate fitness and 12.8% in Frail (Fisher x2 =12.398,P=0.002).The median PFS for the three groups were 31 months,24 months and 13 months (x2 =17.832,P < 0.001).The median OS was not reached for Fit,58 months for Intermediate fitness and 25 months for Frail (x2=40.678,P< 0.001).In 47 Frail cases,patients who received chemotherapy containing new drugs (proteasome inhibitor or immune-modulator) had a longer PFS (17 months vs 9 months,x2 =6.454,P =0.011) and patients who achieved CR had prolonged PFS and OS than non-CR (PFS:24 months vs 12 months,x2 =4.117,P =0.042;OS:37 months vs 25 months,x2 =6.507,P=0.011).Conclusion The health status of the elderly MM patients was associated with better response and longer PFS and OS.Given on those with poor health status,new drugs may have better PFS and prolonged OS.
Author 陈海敏 周帆 韦苇 彭嵘 石昊天 侯健
AuthorAffiliation 第二军医大学长征医院闸北分院血液科,上海200070 第二军医大学长征医院血液科
AuthorAffiliation_xml – name: 第二军医大学长征医院闸北分院血液科, 上海,200070%第二军医大学长征医院血液科
Author_FL Shi Haotian
Wei Wei
Chen Haimin
Zhou Fan
Peng Rong
Hou Jian
Author_FL_xml – sequence: 1
  fullname: Chen Haimin
– sequence: 2
  fullname: Zhou Fan
– sequence: 3
  fullname: Wei Wei
– sequence: 4
  fullname: Peng Rong
– sequence: 5
  fullname: Shi Haotian
– sequence: 6
  fullname: Hou Jian
Author_xml – sequence: 1
  fullname: 陈海敏 周帆 韦苇 彭嵘 石昊天 侯健
BookMark eNo9jz1PwkAYx2_AREC_hINx4Xzau_baTUN8S0hc2Mm1veMlciiNEZzQ6CAORF0MqxiNOhkH0OCnaSl8C89gnJ7k__zyf8mglGoogdCaAZgwG9b9Osc1XA1DhcG0SM5kJsMmGAyDiwFICqX_9UWUCcMaANV_mkYbLom-rxnE72fR12M07MaDfty7mXSeZi_Ps9e75H4wOX-Ydi6T_kU0_Ig_u8nVKDkfxb3udPwWj2-X0ILkB6FY_rtZVNzeKuZ3c4X9nb38ZiHnW45Otrj0HMIDZlMaSOJbtscdU_i-LcFzqPCASCBu4FEbhB0Q6Ri6oyuMgAvOTZJFq3PbE64kV-VSrXHcVDqwdFpptVu_Y8HVUzW4Mgf9SkOVj6oaPWxW67zZLtmMmJQZ1CE_PFpwUQ
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.0253-2727.2017.09.003
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Clinical features and prognosis of 93 elderly patients with multiple myeloma
DocumentTitle_FL Clinical features and prognosis of 93 elderly patients with multiple myeloma
EndPage 748
ExternalDocumentID zhxyx201709003
673247148
GrantInformation_xml – fundername: 上海市科委科研计划; 上海市静安区医学科研青年项目; Shanghai Science and Technology Committee Research Program; Shanghai Jingan District Medical Research Youth Program
  funderid: (14411973400); (2016QN04); (14411973400); (2016QN04)
GroupedDBID ---
-05
2B.
2C~
2RA
92F
92I
92L
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
F5P
OK1
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
PSX
ID FETCH-LOGICAL-c583-25afb83ad7644df3c56ba82ecc6f0b84eb03f039db460e6d3f810049e1daeaa23
ISSN 0253-2727
IngestDate Thu May 29 04:00:17 EDT 2025
Wed Feb 14 09:56:51 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 9
Keywords 多发性骨髓瘤
日常生活能力量表
Instrumental activities of daily living scale
Multiple myeloma
Charlson合并症指数
Basic activities of daily living scale
日常生活能力评分
Charlson comorbidity index
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c583-25afb83ad7644df3c56ba82ecc6f0b84eb03f039db460e6d3f810049e1daeaa23
Notes Multiple myeloma; Basic activities of daily living scale; Instrumental activities ofdaily living scale; Charlson comorbidity index
Objective To explore the clinical features and prognostic factors of elderly MM patients. Methods A retrospectively analysis of clinical characteristics in 93 newly diagnosed MM patients with more than 70 years of old between August 2011 and August 2016. Based on age, basic activities of daily living scale, instrumental activities of daily living scale, Charlson comorbidity index at diagnosis, patients were divided into three groups: Fit (score = 0, n = 15), Intermediate fitness (score = 1, n = 31 ), Frail (score≥2, n = 47) according to a geriatric assessment system proposed by Antonio Palumbo et al. The treatment response rate, progression free survival time (PFS) and overall survival (OS) of the three groups were analyzed. Results Complete remission was 60.0% in Fit, 22.6% in Intermediate fitness and 12.8% in Frail (Fisher χ2 = 12.398, P = 0.002). The median PFS for the three gro
PageCount 5
ParticipantIDs wanfang_journals_zhxyx201709003
chongqing_primary_673247148
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 中华血液学杂志
PublicationTitleAlternate Chinese Journal of Hematology
PublicationTitle_FL Chinese Journal of Hematology
PublicationYear 2017
Publisher 第二军医大学长征医院闸北分院血液科, 上海,200070%第二军医大学长征医院血液科
Publisher_xml – name: 第二军医大学长征医院闸北分院血液科, 上海,200070%第二军医大学长征医院血液科
SSID ssj0042014
ssib051368330
ssib017477332
ssib001103535
ssib058574913
Score 2.1187084
Snippet 目的探索老年多发性骨髓瘤(MM)患者的临床特征以及转归。方法回顾性分析2011年8月至2016年8月第二军医大学长征医院收治的93例70岁以上的初发MM患者的临床特征,根据患者初...
目的 探索老年多发性骨髓瘤(MM)患者的临床特征以及转归.方法 回顾性分析2011年8月至2016年8月第二军医大学长征医院收治的93例70岁以上的初发MM患者的临床特征,根据患者初...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 744
SubjectTerms Charlson合并症指数
多发性骨髓瘤
日常生活能力评分
日常生活能力量表
Title 93例70岁以上多发性骨髓瘤患者的临床特点及转归
URI http://lib.cqvip.com/qk/93752X/201709/673247148.html
https://d.wanfangdata.com.cn/periodical/zhxyx201709003
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAQN
  databaseName: PubMed Central
  issn: 0253-2727
  databaseCode: RPM
  dateStart: 20150101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  omitProxy: true
  ssIdentifier: ssj0042014
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LahRBsIkRRA-iqBjjIwcbhGXj7PT062ZPdpcg6ClCbss8EwQ3PhKIOcWgB-MhqBfJ1YiinsRDosSv2c0mf2FVzWSzBPF1GWq6a6qqu5qu6p7qasaumtQ3sc5F1RdBVg2yTFUjMItVaVSuRAoWj26eu3VbTd4Jbk7L6aEjJwailhbm4_Fk6ZfnSv5Hq1AGesVTsv-g2T5RKAAY9AtP0DA8_0rHVvBGwMMGN6H2eEPy0AfPkMpC7iQBhhuHVS7glgDT5BZwFMY4OM0bljvHnSEg5EhSc2sQH3F87qDEILKRVOW4CUrKYUBMHbHQ3FgeWgJ8AogXVgFmnbsJQq7z4la6fY-4JOXqhF_npoH4roYcQYBQYaNQfqCgsMTWkT6Sgob0rSiKby03hj6CSk24KEIFkaHJ2EZJHaIqhN4kivAecqMrpXSFIEDBmgq1t8lDQbQGetLZStnzrklyA3U5uIFSnBQtZ1hfwiDVRXKCfXMgzMCwtwNzuy4SVZZugi4ShB62QBhjBMMmuReN3yUm430mGEeoKamuJw6sbz8mUmnwbTWsTo-woz5uLh3aegI_TcgD3xZWkloP5J6TNaEMRQoXbkgA3Ch32j77Y-xaKd_1P0mHeUZm59ozD8B7osNs7Txqzwz4XVOn2MlywTTmitF_mg0tzZ5hN6zo_Hihve6XJ53v7zqbq92N9e7ay53l93sfP-x9et17s7Gz8nZ3-Vlv_Wln82v322rv-VZvZau7trq7_bm7_eosm2o2piYmq-VdINVEGpBQRnlsRJRq8N_TXCRSxZHxYf5RuRebIIs9kXvCpnGgvEylIjeYCtFmtTTKosgX59hwe66dnWdjKveDVCZGJnh3hE7iNIriKMjTGixNPOGPsNF-41v3i5Qvrb5yRtiVsjta5UTwqLU0u_h4EbvPw98CF377_Sg7jpjFJt5FNjz_cCG7BG7tfHyZ1P0TRRB61A
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=93%E4%BE%8B70%E5%B2%81%E4%BB%A5%E4%B8%8A%E5%A4%9A%E5%8F%91%E6%80%A7%E9%AA%A8%E9%AB%93%E7%98%A4%E6%82%A3%E8%80%85%E7%9A%84%E4%B8%B4%E5%BA%8A%E7%89%B9%E7%82%B9%E5%8F%8A%E8%BD%AC%E5%BD%92&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%A1%80%E6%B6%B2%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E9%99%88%E6%B5%B7%E6%95%8F+%E5%91%A8%E5%B8%86+%E9%9F%A6%E8%8B%87+%E5%BD%AD%E5%B5%98+%E7%9F%B3%E6%98%8A%E5%A4%A9+%E4%BE%AF%E5%81%A5&rft.date=2017&rft.issn=0253-2727&rft.volume=38&rft.issue=9&rft.spage=744&rft.epage=748&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-2727.2017.09.003&rft.externalDocID=673247148
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93752X%2F93752X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhxyx%2Fzhxyx.jpg